Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of allisartan isoproxil tablets in healthy Chinese participants
CTR20253404Phase 4Active
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of allisartan isoproxil in essential hypertension (3 arms), sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd. Primary endpoints: Adverse events, Serious adverse events and 5 more. Started Aug 2025; status: active.
02
Drugs
allisartan isoproxil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20253404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253404.